RACEMIC-2-DI-T-BUTYLPHOSPHINO-1, 1'-BINAPHTHYL, 98%
Product Information
Molecular Formula
C28H31P
Molecular Weight
398.53
Description
RACEMIC-2-DI-T-BUTYLPHOSPHINO-1, 1'-BINAPHTHYL, 98% is a chiral molecule exhibiting enantiomeric purity of 98%. Functioning as an imperative constituent for the synthesis of pioneering pharmaceuticals and catalysts, this multifaceted compound greatly facilitates diverse chemical processes.
Synonyms
rac-2-(Di-tert-butylphosphino)-1,1'-binaphthyl
IUPAC Name
ditert-butyl-(1-naphthalen-1-ylnaphthalen-2-yl)phosphane
SMILES
CC(C)(C)P(C1=C(C2=CC=CC=C2C=C1)C3=CC=CC4=CC=CC=C43)C(C)(C)C
InChI
InChI=1S/C28H31P/c1-27(2,3)29(28(4,5)6)25-19-18-21-13-8-10-16-23(21)26(25)24-17-11-14-20-12-7-9-15-22(20)24/h7-19H,1-6H3
InChI Key
QGBQGMHXBSLYLZ-UHFFFAOYSA-N
Melting Point
144-148 °C
Flash Point
Not applicable
Purity
97%
Safety Information
Hazards
H315 - H319 - H335
Precautionary Statement
P302 + P352 - P305 + P351 + P338
Computed Properties
XLogP3
7.6
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
0
Rotatable Bond Count
4
Exact Mass
398.216337987 g/mol
Monoisotopic Mass
398.216337987 g/mol
Topological Polar Surface Area
0Ų
Heavy Atom Count
29
Formal Charge
0
Complexity
524
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| JP-2021035987-A | Pest control method | 2020-11-16 |
| JP-2021035988-A | Plant pathogenic microorganism control composition and plant pathogenic microorganism control method | 2020-11-16 |
| WO-2022055963-A1 | Heterocyclic pericondensed cdc7 kinase inhibitors for the treatment of cancer | 2020-09-10 |
| WO-2022026706-A1 | Combinations for the treatment of cancer | 2020-07-31 |
| CN-112062771-A | Synthesis and application of multi-type organelle fluorescent probe containing heteroatom polycyclic aromatic hydrocarbon | 2020-07-08 |
| WO-2021249417-A1 | Heterocyclic compound and derivative thereof | 2020-06-09 |
| WO-2021249877-A1 | Intermediates and processes for the preparation of tolvaptan and its derivatives | 2020-06-08 |
| WO-2021219019-A1 | Heterocyclic glp-1 agonists | 2020-04-29 |
| WO-2021113492-A1 | Cyclic compounds and methods of using same | 2019-12-06 |
| WO-2021090030-A1 | Gpr52 modulator compounds | 2019-11-08 |
